Additionally, LEP stimulates breast cancer cell proliferation and migration via MAPK pathway activation [19], and modulates the PI3K/AKT pathway to facilitate epithelial–mesenchymal transition (EMT), migration, and angiogenesis [20]. This evidence concerns the gene AKT1 and breast cancer.